Panagiotis Mavros Selected Research

LDL Cholesterol

7/2017	Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial.
4/2015	Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Panagiotis Mavros Research Topics

Disease

7	Type 2 Diabetes Mellitus (MODY) 07/2017 - 04/2010
5	Schizophrenia (Dementia Praecox) 03/2023 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2017 - 04/2010
3	Osteoarthritis 02/2015 - 12/2003
2	Chronic Renal Insufficiency 06/2015 - 07/2010
2	Pain (Aches) 02/2015 - 05/2004
2	Vomiting 09/2006 - 05/2004
2	Nausea 09/2006 - 05/2004
2	Arthritis (Polyarthritis) 05/2004 - 12/2003
2	Rheumatoid Arthritis 05/2004 - 12/2003
1	Heart Failure 04/2024
1	COVID-19 10/2023
1	Psychotic Disorders (Schizoaffective Disorder) 03/2023
1	Residual Neoplasm 01/2022
1	Multiple Myeloma 01/2022
1	Hypercholesterolemia 07/2017
1	Atherosclerosis 07/2017
1	Myocardial Infarction 06/2017
1	Stroke (Strokes) 06/2017
1	Hemorrhage 06/2017
1	Transient Ischemic Attack 06/2017
1	Hypertension (High Blood Pressure) 06/2015
1	Knee Osteoarthritis 02/2015
1	Candidiasis (Moniliasis) 01/2013
1	Hypoglycemia (Reactive Hypoglycemia) 05/2012
1	Osteoporosis 06/2007
1	Neoplasms (Cancer) 09/2006
1	Peptic Ulcer (Peptic Ulcers) 09/2006
1	Invasive Fungal Infections 06/2006
1	Low Back Pain (Lumbago) 05/2004
1	Mycoses (Diseases, Fungus) 03/2004

Drug/Important Bio-Agent (IBA)

5	Antipsychotic Agents (Antipsychotics)IBA 03/2023 - 01/2021
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 07/2010
3	Metformin (Glucophage)FDA LinkGeneric 07/2017 - 07/2010
3	Sitagliptin Phosphate (Januvia)FDA Link 07/2017 - 04/2010
2	Paliperidone Palmitate FDA Link 03/2023 - 01/2021
2	oxidized low density lipoproteinIBA 07/2017 - 04/2015
2	LDL CholesterolIBA 07/2017 - 04/2015
2	Antihypertensive Agents (Antihypertensives)IBA 06/2015 - 07/2010
2	AntiemeticsIBA 09/2006 - 05/2004
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2006 - 05/2004
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2024
1	remdesivirIBA 10/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023
1	daratumumabIBA 01/2022
1	Ezetimibe (Zetia)FDA Link 07/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Simvastatin (Zocor)FDA LinkGeneric 07/2017
1	Clopidogrel (Plavix)FDA Link 06/2017
1	AnticoagulantsIBA 06/2017
1	CholesterolIBA 04/2015
1	Analgesics (Analgesic Drugs)IBA 02/2015
1	Fluconazole (Zonal)FDA LinkGeneric 01/2013
1	LipidsIBA 07/2010
1	CreatinineIBA 07/2010
1	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2010
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2010
1	IncretinsIBA 04/2010
1	Exenatide (Byetta)FDA Link 04/2010
1	Bone Density Conservation AgentsIBA 06/2007
1	Vitamin D FDA LinkGeneric 06/2007
1	Diphosphonates (Bisphosphonates)IBA 06/2007
1	Amphotericin B (Amphotericin)FDA LinkGeneric 06/2006
1	EmeticsIBA 05/2004
1	EtoricoxibIBA 05/2004
1	Celecoxib (Celebrex)FDA Link 12/2003
1	rofecoxib (Vioxx)FDA Link 12/2003

Therapy/Procedure

8	Therapeutics 03/2023 - 06/2006
5	Injections 03/2023 - 04/2010
2	Drug Therapy (Chemotherapy) 09/2006 - 05/2004
1	Secondary Prevention 06/2017
1	Glycemic Control 04/2010
1	Aftercare (After-Treatment) 09/2006
1	Length of Stay 03/2004